Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Deepika Malik MD

Deepika Malik MD

Faculty, Department of Ophthalmology, Drexel University College of Medicine; Associate Professor, Department of Ophthalmology at Philadelphia College of Osteopathic Medicine; Vitreoretinal Surgery Associate at Moore Eye Institute, Philadelphia, PA

Deepika Malik, MD, is a highly experienced, fellowship-trained vitreoretinal surgeon with expertise in retinal detachments, macular disorders and retinal vein occlusions. She completed surgical vitreoretinal fellowship at Gavin Herbert Eye Institute at the University of California-Irvine, CA.  

Dr Malik is Faculty, Department of Ophthalmology, Drexel University College of Medicine; Associate Professor, Department of Ophthalmology at Philadelphia College of osteopathic Medicine; and Vitreoretinal Surgery Associate at Moore eye Institute, Greater Philadelphia Area.

Dr. Malik is an accomplished researcher in extensive national clinic trials conducted to evaluate the efficacy of drugs and devices in the treatment of retinal disorders. Dr Malik has significant experience in teaching, publishing articles and journals on retinal diseases.  

Disclosures

Relevant disclosures: Dr. Malik is an Advisory Board Member at Allergan. She also makes the following financial disclosures: financial disclosures: Allergan & Alimera Sciences.

Recent Contributions to PracticeUpdate:

  1. Five-Year Incidence and Visual Acuity Outcomes for Intravitreal Therapy in Bilateral nAMD
  2. Visual Acuity Outcomes and Anti-VEGF Therapy Intensity in Diabetic Macular Edema
  3. Characterization of Disease Progression in the Initial Stages of Retinopathy in Type 2 Diabetes
  4. Abicipar in Neovascular Age‐Related Macular Degeneration
  5. Long-Term Outcomes After Idiopathic Epiretinal Membrane Surgery
  6. The Value of Prior Response to Anti-VEGF for Age-Related Macular Degeneration
  7. First Failed Macular Hole Surgery or Reopening of a Previously Closed Hole: Do We Gain by Reoperating?
  8. Incidence of Glaucoma or Ocular Hypertension After Repeated Anti-Vascular Endothelial Growth Factor Injections for Macular Degeneration
  9. Incidence of Macular Atrophy Following Untreated Neovascular Age-Related Macular Degeneration
  10. Effects of Intravitreal Anti-VEGF Therapy on Glaucoma-Like Progression in Susceptible Eyes

Most Read This Week

Recently Updated